All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Childhood obesity continues to be a growing problem in out country. So, should the government regulate food advertising like it did with cigarettes?

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

A front-of-package food label would be a great educational tool. The Trump administration should keep it.

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.